Skip to content
LexBuild

Request for Information-Revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation; Extension of Comment Period

---
identifier: "/us/fr/2019-20419"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Request for Information-Revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation; Extension of Comment Period"
title_number: 0
title_name: "Federal Register"
section_number: "2019-20419"
section_name: "Request for Information-Revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation; Extension of Comment Period"
positive_law: false
currency: "2019-09-20"
last_updated: "2019-09-20"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2019-20419"
document_type: "notice"
publication_date: "2019-09-20"
agencies:
  - "Health and Human Services Department"
fr_citation: "84 FR 49544"
fr_volume: 84
comments_close_date: "2019-10-10"
fr_action: "Notice; extension of comment period."
---

#  Request for Information—Revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation; Extension of Comment Period

**AGENCY:**

Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.

**ACTION:**

Notice; extension of comment period.

**SUMMARY:**

The Office of the Assistant Secretary for Health published a document in the *Federal Register* of August 27, 2019, requesting public comment related to revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation. Due to numerous requests of an extension to the public comment period, this document is announcing an extension.

**DATES:**

To be assured consideration, comments must be received at the address provided below no later than 5:00 p.m. ET on October 10, 2019.

**FOR FURTHER INFORMATION CONTACT:**

Mr. James Berger, (202) 795-7608; *[email protected].*

Dated: September 17, 2019.

James J. Berger,

Senior Advisor for Blood and Tissue Policy, Office of the Assistant Secretary for Health.